Revenio Group Corporation (REG1V) - Total Liabilities
Based on the latest financial reports, Revenio Group Corporation (REG1V) has total liabilities worth €30.80 Million EUR (≈ $36.01 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore REG1V cash flow conversion to assess how effectively this company generates cash.
Revenio Group Corporation - Total Liabilities Trend (2000–2024)
This chart illustrates how Revenio Group Corporation's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Revenio Group Corporation to evaluate the company's liquid asset resilience ratio.
Revenio Group Corporation Competitors by Total Liabilities
The table below lists competitors of Revenio Group Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Perfect Group Corp Ltd Class A
SHG:603059
|
China | CN¥1.15 Billion |
|
Symtek Automation Asia Co Ltd
TW:6438
|
Taiwan | NT$4.16 Billion |
|
NationGate Holdings Berhad
KLSE:0270
|
Malaysia | RM1.30 Billion |
|
Chongqing Machinery & Electric Co. Ltd
F:CE3
|
Germany | €9.95 Billion |
|
Zaptec AS
OL:ZAP
|
Norway | Nkr425.90 Million |
|
Shanxi Yongdong Chemistry Industry Co Ltd
SHE:002753
|
China | CN¥1.03 Billion |
|
Aerostar Bacau
RO:ARS
|
Romania | RON188.66 Million |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
F:GU5
|
Germany | €47.87 Billion |
Liability Composition Analysis (2000–2024)
This chart breaks down Revenio Group Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Revenio Group Corporation market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Revenio Group Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Revenio Group Corporation (2000–2024)
The table below shows the annual total liabilities of Revenio Group Corporation from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €33.63 Million ≈ $39.32 Million |
-10.37% |
| 2023-12-31 | €37.52 Million ≈ $43.86 Million |
-16.95% |
| 2022-12-31 | €45.17 Million ≈ $52.81 Million |
-2.12% |
| 2021-12-31 | €46.15 Million ≈ $53.96 Million |
+3.23% |
| 2020-12-31 | €44.71 Million ≈ $52.27 Million |
-1.58% |
| 2019-12-31 | €45.43 Million ≈ $53.11 Million |
+1029.49% |
| 2018-12-31 | €4.02 Million ≈ $4.70 Million |
+31.65% |
| 2017-12-31 | €3.06 Million ≈ $3.57 Million |
-23.76% |
| 2016-12-31 | €4.01 Million ≈ $4.68 Million |
+18.13% |
| 2015-12-31 | €3.39 Million ≈ $3.97 Million |
-53.37% |
| 2014-12-31 | €7.28 Million ≈ $8.51 Million |
-5.26% |
| 2013-12-31 | €7.68 Million ≈ $8.98 Million |
-25.65% |
| 2012-12-31 | €10.33 Million ≈ $12.07 Million |
+23.97% |
| 2011-12-31 | €8.33 Million ≈ $9.74 Million |
-16.56% |
| 2010-12-31 | €9.98 Million ≈ $11.67 Million |
-7.80% |
| 2009-12-31 | €10.83 Million ≈ $12.66 Million |
-4.59% |
| 2008-12-31 | €11.35 Million ≈ $13.27 Million |
-38.31% |
| 2007-12-31 | €18.40 Million ≈ $21.51 Million |
+193.80% |
| 2006-12-31 | €6.26 Million ≈ $7.32 Million |
+9.02% |
| 2005-12-31 | €5.74 Million ≈ $6.72 Million |
+65.00% |
| 2004-12-31 | €3.48 Million ≈ $4.07 Million |
-35.76% |
| 2003-12-31 | €5.42 Million ≈ $6.34 Million |
-28.76% |
| 2002-12-31 | €7.61 Million ≈ $8.89 Million |
-54.55% |
| 2001-12-31 | €16.73 Million ≈ $19.56 Million |
-23.63% |
| 2001-09-30 | €21.91 Million ≈ $25.62 Million |
-5.56% |
| 2000-12-31 | €23.20 Million ≈ $27.13 Million |
-- |
About Revenio Group Corporation
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pre… Read more